Shilpa Medicare gets 2 observations from AGES, Austria for Unit 4 of Jadcherla facility
Written By : Ruchika Sharma
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2024-01-29 10:00 GMT | Update On 2024-03-23 11:42 GMT
Advertisement
Karnataka: Shilpa Medicare has received two minor observations from AGES, Austria at the conclusion of a Europe GMP inspection at the Company's Unit 4 of Jadcherla facility.
"Shilpa Medicare Limited, Unit 4, Jadcherla, Telangana, India had Europe GMP inspection by AGES, Austria from 22 January, 2024 until 26 January, 2024," the Company informed in a BSE filing.
This inspection has concluded with two minor observations.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.